2008
DOI: 10.1097/inf.0b013e318134286d
|View full text |Cite
|
Sign up to set email alerts
|

Risk Factors for Retinochoroiditis During the First 2 Years of Life in Infants With Treated Congenital Toxoplasmosis

Abstract: A delay of >8 weeks between maternal seroconversion and the beginning of treatment, female gender, and especially cerebral calcifications are risk factors for retinochoroiditis during the first 2 years of life in infants treated for congenital toxoplasmosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
83
3
13

Year Published

2009
2009
2024
2024

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 114 publications
(101 citation statements)
references
References 26 publications
2
83
3
13
Order By: Relevance
“…25 In the current study, the longer followup times allowed us to assess the longterm impact of several prognostic factors that were identified in the same cohort of patients at an earlier stage 26 and that have been likewise recognized by other investigators. 4,23 Gender had no significant impact. The decreasing risk of developing retinochoroiditis with increasing gestational age at the time of maternal infection and with each additional month until CT postnatal diagnosis in children was confirmed.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…25 In the current study, the longer followup times allowed us to assess the longterm impact of several prognostic factors that were identified in the same cohort of patients at an earlier stage 26 and that have been likewise recognized by other investigators. 4,23 Gender had no significant impact. The decreasing risk of developing retinochoroiditis with increasing gestational age at the time of maternal infection and with each additional month until CT postnatal diagnosis in children was confirmed.…”
Section: Discussionmentioning
confidence: 94%
“…Indirect evidence indicates that this measure can reduce the short-term severity of toxoplasmosis. [2][3][4][5] Whether the long-term outcome is thereby affected is unknown because no prospective data on the evolution beyond the sixth year of age in treated children are available. Such data would be invaluable in making follow-up and treatment decisions.…”
mentioning
confidence: 99%
“…In case of congenital origin, the risk of ocular disease depends on the trimester of pregnancy when infection occurred, and on whether or not treatment was administered to the mother during pregnancy. In one study, a period exceeding 8 weeks between maternal infection and the beginning of treatment, female gender, and especially cerebral calcifications were risk factors for retinochoroiditis [10]. No significant association was found in other cohort studies between gestational age at maternal infection, prenatal treatment and the risk of developing OT [11,12].…”
Section: A Complication Of Acquired and Congenital Infectionsmentioning
confidence: 98%
“…Peyron et al [84] stated that "treating CT has little effect on the quality of life and visual function of the affected individuals". However, Kieffer et al [10] showed that a period exceeding 8 weeks between maternal infection and the beginning of treatment was a risk factor for retinochoroiditis; therefore emphasizing the need to prevent and treat CT. Evidence for the effectiveness of prenatal or postnatal treatment for CT is still needed.…”
Section: Efficient Treatments Are Available But There Is No Real Meanmentioning
confidence: 99%
“…In a 19-month follow-up, Holfeld found that pyrimethamine plus sulfonamide was effective in reducing the severity of the disease in comparison with a group of historical controls (Holfeld et al 1989). We demonstrated that a delay of more than eight weeks between maternal seroconversion and treatment onset was associated with an increased risk of retinochorioditis during the first two years of life in infected infants (Kieffer et al 2008).…”
mentioning
confidence: 99%